EXTRA UNLIMITED VIEW
FROM STANDARD CATARACT SURGERY TOVITREORETINAL SURGERY
The ASPIRA®-aXA with its extended optic diameter of 7.0 mm offers a magnified view into the outer fundus periphery. The IOL effectively reduces dysphotopsia and offers excellent stability in the capsular bag. At the same time, the ASPIRA®-aXA allows comfortable implantation through small incisions, enabling simple and rapid integration into the surgical routine.1,2,3
SMART FACTS
The innovative IOL design is particularly suitable for patients with wide pupils, traumatic mydriasis, iris defects, an increased risk of retinal diseases or the need for combined vitreoretinal surgery.
EXTENDED 7.0 MM XL OPTICS
The panoramic IOL provides excellent intraoperative insight and improved visualization for subsequent screening examinations in the context of retinal diseases and combined vitroretinal procedures.2
Excellent intraoperative view due to enlarged capsulorhexis2
Visualization when using a conventional IOL
Display when using the
ASPIRA®-aXA
EFFECTIVE REDUCTION OF DYSPHOTOPSIA
The incidence, frequency and extent of dysphotopsia are lower in patients treated with ASPIRA®-aXA compared to patients treated with a 6.0 mm lens.1 All patients showed almost complete disappearance of dysphotopsia after bag-to-bag exchange with the 7.0 mm ASPIRA®-aXA. The lens is also characterized by high spontaneous tolerance.4
Simulated light beam guidance with conventional IOL
Reflection from the IOL edge
can lead to the perception of positive dysphotopsia5
Dark area
can lead to the perception
of negative
dysphotopsia6
Simulated light beam guidance with ASPIRA®-aXA
Effective reduction
of positive and negative dysphotopsia1
EXCELLENT OVERALL STABILITY
A large contact surface ensures excellent stability in the capsular bag. The double positioning mark (Quattor point technology) ensures excellent placement. The cut-out haptics serve as an absorption element and for anchoring. The ASPIRA®-aXA thus offers stability even in myopic eyes or in extreme situations such as intravitreal injections or combined vitrectomies.2,3
EXPERT OPINION ON THE ASPIRA®-aXA
“The particular advantage for me is the excellent stability of the IOL position and the peripheral view, especially when using gas and oil tamponades. Even after several years, there were no abnormalities such as calcification or deposits of hydrophilic material.”
Priv.-Doz. Dr. med. Jens Schrecker, Glauchau.
“The ASPIRA®-aXA combines tilt-free seating and excellent A-constant fidelity with optical precision and, due to its size, is the number one monofocal IOL for eyes with a WTW of more than 12.0 mm and/or large pupils.”
Dr. med. Eckhard Becker, Oranienburg.
TECHNICAL DATA
- Monofocal posterior chamber IOL
- Aspherical aberration-free surface
- 360° lens epithelial cell barrier
- Optics diameter: 7.0 mm | total diameter: 11.0 mm
- UV-absorbing hydrophilic acrylic (water content 26 % at 35° C)
- Cut-out haptics
- XL delivery range from -10.0 dpt for highly myopic patients
- Abbe number: 56
- Refractive index: 1.46
XL delivery area
PRELOADED IN THE SAFELOADER® | IN THE COMPACT LINE | |
|---|---|---|
ASPIRA®-aXA | 10.0 to 30.0 in 0.5 dpt steps | -10.0 to 9.0 in 1.0 dpt increments 10.0 to 30.0 in 0.5 dpt increments |
APPLICATION
Whether you opt for the space-saving Compact Line or the Safeloader preloaded implantation system, we recommend the Medicel AccuJectTM in the exclusive yellow HumanOptics version for both systems.
APPLICATION TEAM
Use our individual calculation service to find the right implant for your patient’s requirements together with us. We offer doctors the opportunity to contact us directly with the calculation values. We calculate the lens based on your specific measurement data!
Do you have medical or technical questions?
Our switchboard (+49 (0) 9131 50 66 5-0) gives you quick access to our specialist departments.
Please note:
The combination of vitrectomy and IOL implantation can influence the expected lens position. For a customized IOL calculation and further details, please contact our Customer Service. The latest constant optimizations can be found at www.humanoptics.com and IOLcon.org
95 % OF OUR CUSTOMERS TRUST THEEXPERTISE OF OUR APPLICATION TEAM.9
REPORTS FROM CLINICAL APPLICATION
Clinical data confirm long-term stability of refraction and position without significant decentration or displacement of the IOL.2,3,7,8
97% of patients were very satisfied or satisfied with their visual outcome 1.5 years after the procedure.
No matter how high the IOL quality, it is only as good as its practical usability. That is why experience reports are usually much more meaningful than theoretical technical data. See for yourself.
Postoperative Lens Rotation of a 7.0 mm Optic IOL with Plate Haptics
Pilger D., Bertelmann E., Brockmann T, et al.
Postoperative Lens Rotation of a 7.0 mm Optic IOL with Plate Haptics
Int J Ophthal Vision Res. 2021 Dec 07;5(1): 014-020.
Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology
Borkenstein AF, Borkenstein EM
Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology
Ophthalmol Ther. 2021 Nov 27.doi: 10.1007/s40123-021-00433-3. Epub 2021 Nov 27.
Performance of a new 7 mm intraocular lens with follow-up over 1.5 years
Schrecker J, Seitz B, Langenbucher A
Performance of a new 7 mm intraocular lens with follow-up over 1.5 years
Ophthalmologist. 2021 Oct 5.doi: 10.1007/s00347-021-01504-3. Online ahead of print.
Dysphotopsiae and functional quality of vision after implantation of an intraocular lens with a 7.0 mm optic and plate haptic design
Bonsemeyer MK, Becker E, Liekfeld A
Dysphotopsiae and functional quality of vision after implantation of an intraocular lens with a 7.0 mm optic and plate haptic design
J Cataract Refract Surg. 2021 Jun 28.doi: 10.1097/j.jcrs.0000000000000735. Online ahead of print.
Rotational Stability, Tilt and Decentration of a New IOL with a 7.0 mm Optic
Wendelstein J, Laubichler P, Fischinger I, et al.
Rotational Stability, Tilt and Decentration of a New IOL with a 7.0 mm Optic
Current Eye Research 2021 Jun;14:1-8
Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa
Borkenstein AF, Borkenstein EM
Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa
Case Rep Opththalmol 2019 Sep;10:304-11.
ASPIRA®-aXA in the media
XL optics as routine in everyday cataract surgery?
Liekfeld, A.
XL optics as routine in everyday cataract surgery?
DGII current 2021; 02:6
The ASPIRA-aXA/-aXAY - The panoramic IOL for retinal surgery
Boden, K.
The ASPIRA-aXA/-aXAY – The panoramic IOL for retinal surgery
Presentation, DOG 2020
Improved Stability, Refractive Results With the Aspira-aXA IOL-A Novel IOL With Enlarged Optic Diameter
Interview with Becker, E. & Schrecker, J.
Improved Stability, Refractive Results With the Aspira-aXA IOL-A Novel IOL With Enlarged Optic Diameter
Cataract Refractive Surgery Today Europe 2020; 03:23
Do you have any questions or would you like to order our products?
Please contact our sales team for an individual consultation, specific information on our products or training measures and surgery shadowing.
Our employees are happy to be there for you EXTRA.
- Bonsemeyer MK, Becker E, Liekfeld A. Dysphotopsia and functional quality of vision after implantation of an intraocular lens with a 7.0 mm optic and plate haptic design. J Cataract Refract Surg. 2022 Jan 1;48(1):75-82.
- Borkenstein AF, Borkenstein EM. Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology. Ophthalmol Ther. 2022 Feb;11(1):443-452.
- Pilger D, et al. Postoperative Lens Rotation of a 7.0 Mm Optic IOL with Plate Haptics. J Ophthalmic Vis Res. 2021;5(1):14-20.
- Rozendal L.R.W., et al. Bag-to-bag intraocular lens exchange with a wide optic intraocular lens for treatment of positive and negative dysphotopsia. Presented at the ESCRS 2021 Congress, Amsterdam, Netherlands.
- Mito T, Kawakami H, Ikoma T, Ukai Y, Tsuchiya M, Kubo E, Sasaki H. Positive dysphotopsia after intrascleral intraocular lens fixation: a case report. BMC Ophthalmol. 2022 Jun 11;22(1):263.
- Holladay JT, Simpson MJ. Negative dysphotopsia: Causes and rationale for prevention and treatment. J Cataract Refract Surg. 2017 Feb;43(2):263-275.
- Schrecker J, et al. Performance of a new 7 mm intraocular lens with follow-up over 1.5 years]. Ophthalmologist. 2022;119(4):367-373.
- Wendelstein J, Laubichler P, Fischinger I, Mariacher S, Beka S, Mursch-Edlmayr A, Siska R, Langenbucher A, Bolz M. Rotational Stability, Tilt and Decentration of a New IOL with a 7.0 mm Optic. Curr Eye Res. 2021 Nov;46(11):1673-1680.
- HumanOptics Data on File, 2021.